Literature DB >> 25710455

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis.

Sara Trabanelli1, Antonio Curti2, Mariangela Lecciso2, Bérengère Salomé3, Carsten Riether4, Adrian Ochsenbein5, Pedro Romero3, Camilla Jandus1.   

Abstract

Entities:  

Keywords:  CD127+ ILCs; acute myeloid leukemia; dysregulated; innate lymphoid cells; treatment naive

Mesh：

Substances：

Year:  2015        PMID： 25710455      PMCID： PMC4486236          DOI： 10.3324/haematol.2014.119602

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Authors:  Maya Eisenring; Johannes vom Berg; Glen Kristiansen; Elisabeth Saller; Burkhard Becher
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

2.  SnapShot: innate lymphoid cells.

Authors:  Gregory F Sonnenberg; Jenny Mjösberg; Hergen Spits; David Artis
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

3.  Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Authors:  J Marius Munneke; Andreas T Björklund; Jenny M Mjösberg; Karin Garming-Legert; Jochem H Bernink; Bianca Blom; Cynthia Huisman; Marinus H J van Oers; Hergen Spits; Karl-Johan Malmberg; Mette D Hazenberg
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

4.  Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation.

Authors:  V Santini; A Gozzini; B Scappini; P Rossi Ferrini
Journal:  Haematologica       Date:  1999-04       Impact factor: 9.941

5.  Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.

Authors:  Kate Stringaris; Takuya Sekine; Ahmad Khoder; Abdullah Alsuliman; Bonnie Razzaghi; Ruhena Sargeant; Jiri Pavlu; Gill Brisley; Hugues de Lavallade; Anushruthi Sarvaria; David Marin; Stephan Mielke; Jane F Apperley; Elizabeth J Shpall; A John Barrett; Katayoun Rezvani
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

6.  Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity.

Authors:  Masashi Ikutani; Tsutomu Yanagibashi; Masaru Ogasawara; Koichi Tsuneyama; Seiji Yamamoto; Yuichi Hattori; Taku Kouro; Atsuko Itakura; Yoshinori Nagai; Satoshi Takaki; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

7.  Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.

Authors:  Ivan P Jovanovic; Nada N Pejnovic; Gordana D Radosavljevic; Jelena M Pantic; Marija Z Milovanovic; Nebojsa N Arsenijevic; Miodrag L Lukic
Journal:  Int J Cancer       Date:  2013-10-10       Impact factor: 7.396

Review 8.  Innate lymphoid cells--a proposal for uniform nomenclature.

Authors:  Hergen Spits; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gerard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

9.  Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model.

Authors:  Stefanie Kirchberger; Daniel J Royston; Olivier Boulard; Emily Thornton; Fanny Franchini; Rose L Szabady; Oliver Harrison; Fiona Powrie
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

Review 10.  Recognition strategies of group 3 innate lymphoid cells.

Authors:  Monica Killig; Timor Glatzer; Chiara Romagnani
Journal:  Front Immunol       Date:  2014-04-01       Impact factor: 7.561
View more
  30 in total

1.  CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

Authors:  Bérengère Salomé; Alejandra Gomez-Cadena; Romain Loyon; Madeleine Suffiotti; Valentina Salvestrini; Tania Wyss; Giulia Vanoni; Dan Fu Ruan; Marianna Rossi; Alessandra Tozzo; Paolo Tentorio; Elena Bruni; Carsten Riether; Eva-Maria Jacobsen; Peter Jandus; Curdin Conrad; Manfred Hoenig; Ansgar Schulz; Katarzyna Michaud; Matteo Giovanni Della Porta; Silvia Salvatore; Ping-Chih Ho; David Gfeller; Adrian Ochsenbein; Domenico Mavilio; Antonio Curti; Emanuela Marcenaro; Alexander Steinle; Amir Horowitz; Pedro Romero; Sara Trabanelli; Camilla Jandus
Journal:  Blood Adv       Date:  2019-11-26

2.  Identification of innate lymphoid cells in single-cell RNA-Seq data.

Authors:  Madeleine Suffiotti; Santiago J Carmona; Camilla Jandus; David Gfeller
Journal:  Immunogenetics       Date:  2017-05-22       Impact factor: 2.846

3.  Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia.

Authors:  Iris de Weerdt; Vera van Hoeven; J Marius Munneke; Sanne Endstra; Tom Hofland; Mette D Hazenberg; Arnon P Kater
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

4.  Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis.

Authors:  Marco Romano; Daria Sollazzo; Sara Trabanelli; Martina Barone; Nicola Polverelli; Margherita Perricone; Dorian Forte; Simona Luatti; Michele Cavo; Nicola Vianelli; Camilla Jandus; Francesca Palandri; Lucia Catani
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

5.  Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy.

Authors:  Jithendra Kini Bailur; Sameet Mehta; Lin Zhang; Natalia Neparidze; Terri Parker; Noffar Bar; Tara Anderson; Mina L Xu; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  Blood Adv       Date:  2017-11-20

Review 6.  Plasticity of innate lymphoid cell subsets.

Authors:  Suzanne M Bal; Korneliusz Golebski; Hergen Spits
Journal:  Nat Rev Immunol       Date:  2020-02-27       Impact factor: 53.106

Review 7.  Roles of cytotoxic and helper innate lymphoid cells in cancer.

Authors:  Camille Guillerey
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

8.  Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor.

Authors:  Matthew R Lordo; Kevin G Wu; Ekaterina Altynova; Nikolas Shilo; Parker Kronen; Ansel P Nalin; Christoph Weigel; Xiaoli Zhang; Jianhua Yu; Christopher C Oakes; Michael A Caligiuri; Aharon G Freud; Bethany L Mundy-Bosse
Journal:  J Immunol       Date:  2021-08-20       Impact factor: 5.426

Review 9.  Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Authors:  Alessandro Allegra; Marco Casciaro; Elena Lo Presti; Caterina Musolino; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2022-05-27

10.  ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

Authors:  Mathieu F Chevalier; Sara Trabanelli; Julien Racle; Bérengère Salomé; Valérie Cesson; Dalila Gharbi; Perrine Bohner; Sonia Domingos-Pereira; Florence Dartiguenave; Anne-Sophie Fritschi; Daniel E Speiser; Cyrill A Rentsch; David Gfeller; Patrice Jichlinski; Denise Nardelli-Haefliger; Camilla Jandus; Laurent Derré
Journal:  J Clin Invest       Date:  2017-06-26       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.